KMR Group Leads New Enrollment Metrix Forum
KMR GROUP, a firm specializing on biopharmaceutical R&D performance, has formed the Enrollment Metrix Forum. As companies strive to implement best recruitment practices, the Forum offers an opportunity to explore critical recruitment issues as well as analyze recruitment processes. Amgen, AZ, Bayer, BMS, J&J, Lilly, Merck, Pfizer, Roche, Shire and UCB are among the inaugural members.
The Enrollment Metrix Forum serves an industry leadership role for the exchange of ideas and the exploration of issues related to enrollment, offering insights that will prove of value to participants; including the use and identification of enrollment performance metrics, how best to incorporate metrics into the planning process, and using KPIs to identify key performance opportunities. The discussions are flexible, and representatives are encouraged to shape their direction.
Results of these exchanges are provided to members in a report format as part of our Enrollment Special Topics Series. The reports, which take input via members through discussion and surveys, are designed to add insight into the rapidly changing recruitment landscape. In addition, members will have access to the KMR Enrollment Metrix Forum website which offers access to the reports in addition to membership information, press releases and an on-line glossary of terms.
The first meeting took focused on "Defining the Critical Metrics for Evaluating Recruitment Processes". Participants will meet again in December. The first report will be an analysis of key recruitment processes and their associated metrics.
Companies interested in learning more about the Enrollment Metrix Forum are encouraged to contact KMR.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
